Peak6 Investments LLC United Therapeutics Corp Transaction History

Peak6 Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$205.19 - $232.99 $519,335 - $589,697	-2,531 Reduced 99.88%	3 $0
Q1 2023 May 12, 2023	BUY	$212.99 - $276.17 $539,077 - $698,986	2,531 Added 84366.67%	2,534 $567,000
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $203 - $244	1 Added 50.0%	3 $1,000
Q2 2022 Aug 12, 2022	SELL	$174.81 - $241.14 $26,745 - $36,894	-153 Reduced 98.71%	2 $1,000
Q1 2022 May 13, 2022	SELL	$166.16 - $213.96 $849,742 - $1.09 Million	-5,114 Reduced 97.06%	155 $28,000
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $1.14 Million - $1.54 Million	-12,265 Reduced 69.95%	5,269 $638,000
Q4 2019 Feb 13, 2020	SELL	$78.31 - $95.34 $5.25 Million - $6.39 Million	-67,005 Reduced 79.26%	17,534 $1.54 Million
Q3 2019 Nov 08, 2019	SELL	$74.85 - $85.99 $4.44 Million - $5.1 Million	-59,312 Reduced 41.23%	84,539 $6.74 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $10.2 Million - $16.2 Million	133,806 Added 1332.07%	143,851 $11.2 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $1.08 Million - $1.27 Million	10,045 New	10,045 $1.18 Million

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.